A PhaseⅠb Study Evaluating Safety and Efficacy of C-CAR011 Treatment in B- NHL Subjects

NCT03483688 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

B-cell Non-Hodgkin Lymphoma

Interventions

BIOLOGICAL: CD19-directed CAR-T cells

Sponsor

Peking Union Medical College Hospital

Collaborators

[object Object]